A novel biomarker associated with EBV infection improves response prediction of immunotherapy in gastric cancer

A novel biomarker associated with EBV infection improves response prediction of immunotherapy in gastric cancer

Abstract Background Novel biomarkers are required in gastric cancer (GC) treated by immunotherapy. Epstein-Barr virus (EBV) infection induces an immune-active tumor microenvironment, while its association with immunotherapy response is still controversial. Genes underlying EBV infection may determin...

Full description

Bibliographic Details
Main Authors: Xiaoqin Li, Fen Xiong, Zhangmin Hu, Qing Tao, Yufei Yang, Xuehan Qiao, Chen Peng, Yuchun Jiang, Miao Han, Kebin Dong, Yi Hua, Wei Zhang, Min Xu, Weiguo Long, Yichuan Xiao, Deqiang Wang
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Journal of Translational Medicine
Subjects:
Epstein-Barr virus
Immunotherapy
Gastric cancer
Biomarker
Online Access:https://doi.org/10.1186/s12967-024-04859-8

Internet

https://doi.org/10.1186/s12967-024-04859-8

Similar Items